OCGN US Equity
Ocugen, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1372299 · FY ends Dec 31$1.48
+0.14 (+10.45%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 100.9M |
| % of shares out | 29.8% |
| Days to cover | 21.6 |
| Δ vs 2026-07-15 | +0.3% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 100,913,607 | +0.3% | 4,681,821 | 21.6 |
| 2026-07-15 | 100,590,405 | -4.6% | 5,336,703 | 18.9 |
| 2026-06-30 | 105,430,735 | +21.8% | 14,922,590 | 7.1 |
| 2026-06-15 | 86,561,503 | +4.3% | 4,682,762 | 18.5 |
| 2026-05-29 | 83,020,405 | +2.4% | 5,795,786 | 14.3 |
| 2026-05-15 | 81,047,338 | +16.3% | 9,926,269 | 8.2 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
